Glaxo Profit Rises for First Time Since 2013, Tops EstimatesBy
Sales of blockbuster medicine Advair plunges 19 percent
Shares climb by 2.2 percent, most in three weeks, in London
GlaxoSmithKline Plc reported its first increase in quarterly profit since 2013, as demand for its vaccines and new drugs helped offset declines in the sales of its blockbuster Advair.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.